advertisement
11.3.3 Apraclonidine, brimonidine (25)
Showing records 1 to 25
Display all abstracts in classification 11.3.3 Apraclonidine, brimonidine
Search within classification 11.3.3 Apraclonidine, brimonidine75296 High Permeability and Intercellular Space Widening With Brimonidine Tartrate Eye Drops in Cultured Stratified Human Corneal Epithelial Sheets
Hashimoto Y
Cornea 2018; 37: 242-247
75338 Comparison of the neuroprotective effects of brimonidine tartrate and melatonin on retinal ganglion cells
Marangoz D
International Ophthalmology 2017; 0:
75497 Formulation and ex vivo-in vivo evaluation of pH-triggered brimonidine tartrate in situ gel for the glaucoma treatment using application of 3 factorial design
Barse RK
Drug Development and Industrial Pharmacy 2018; 44: 800-807
75108 Severe Corneal Disorders Developed After Brimonidine Tartrate Ophthalmic Solution Use
Maruyama Y
Cornea 2017; 36: 1567-1569
75497 Formulation and ex vivo-in vivo evaluation of pH-triggered brimonidine tartrate in situ gel for the glaucoma treatment using application of 3 factorial design
Tagalpallewar AA
Drug Development and Industrial Pharmacy 2018; 44: 800-807
75296 High Permeability and Intercellular Space Widening With Brimonidine Tartrate Eye Drops in Cultured Stratified Human Corneal Epithelial Sheets
Yokoo S
Cornea 2018; 37: 242-247
75338 Comparison of the neuroprotective effects of brimonidine tartrate and melatonin on retinal ganglion cells
Guzel E
International Ophthalmology 2017; 0:
75108 Severe Corneal Disorders Developed After Brimonidine Tartrate Ophthalmic Solution Use
Ikeda Y
Cornea 2017; 36: 1567-1569
75338 Comparison of the neuroprotective effects of brimonidine tartrate and melatonin on retinal ganglion cells
Eyuboglu S
International Ophthalmology 2017; 0:
75108 Severe Corneal Disorders Developed After Brimonidine Tartrate Ophthalmic Solution Use
Yokoi N
Cornea 2017; 36: 1567-1569
75497 Formulation and ex vivo-in vivo evaluation of pH-triggered brimonidine tartrate in situ gel for the glaucoma treatment using application of 3 factorial design
Kokare CR
Drug Development and Industrial Pharmacy 2018; 44: 800-807
75296 High Permeability and Intercellular Space Widening With Brimonidine Tartrate Eye Drops in Cultured Stratified Human Corneal Epithelial Sheets
Usui T; Tsubota Y
Cornea 2018; 37: 242-247
75338 Comparison of the neuroprotective effects of brimonidine tartrate and melatonin on retinal ganglion cells
Gumusel A
International Ophthalmology 2017; 0:
75497 Formulation and ex vivo-in vivo evaluation of pH-triggered brimonidine tartrate in situ gel for the glaucoma treatment using application of 3 factorial design
Sharma JP
Drug Development and Industrial Pharmacy 2018; 44: 800-807
75108 Severe Corneal Disorders Developed After Brimonidine Tartrate Ophthalmic Solution Use
Mori K
Cornea 2017; 36: 1567-1569
75338 Comparison of the neuroprotective effects of brimonidine tartrate and melatonin on retinal ganglion cells
Seckin I
International Ophthalmology 2017; 0:
75108 Severe Corneal Disorders Developed After Brimonidine Tartrate Ophthalmic Solution Use
Kato H
Cornea 2017; 36: 1567-1569
75497 Formulation and ex vivo-in vivo evaluation of pH-triggered brimonidine tartrate in situ gel for the glaucoma treatment using application of 3 factorial design
Sharma PK
Drug Development and Industrial Pharmacy 2018; 44: 800-807
75296 High Permeability and Intercellular Space Widening With Brimonidine Tartrate Eye Drops in Cultured Stratified Human Corneal Epithelial Sheets
Yamagami S
Cornea 2018; 37: 242-247
75108 Severe Corneal Disorders Developed After Brimonidine Tartrate Ophthalmic Solution Use
Ueno M
Cornea 2017; 36: 1567-1569
75338 Comparison of the neuroprotective effects of brimonidine tartrate and melatonin on retinal ganglion cells
Ciftci F
International Ophthalmology 2017; 0:
75108 Severe Corneal Disorders Developed After Brimonidine Tartrate Ophthalmic Solution Use
Kinoshita S
Cornea 2017; 36: 1567-1569
75338 Comparison of the neuroprotective effects of brimonidine tartrate and melatonin on retinal ganglion cells
Yilmaz B
International Ophthalmology 2017; 0:
75108 Severe Corneal Disorders Developed After Brimonidine Tartrate Ophthalmic Solution Use
Sotozono C
Cornea 2017; 36: 1567-1569
75338 Comparison of the neuroprotective effects of brimonidine tartrate and melatonin on retinal ganglion cells
Yalvac I
International Ophthalmology 2017; 0: